Latest Breaking News On - Okamura - Page 1 : comparemela.com

Elpiscience and Astellas Enter into Research Collaboration and License Agreement for Novel Bispecific Macrophage Engager

Elpiscience and Astellas Enter into Research Collaboration and License Agreement for Novel Bispecific Macrophage Engager
webwire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from webwire.com Daily Mail and Mail on Sunday newspapers.

Darren jiNaoki okamuraAdam pearsonElpiscience biopharma ltdAreas of interest astellas pharma incResearch collaborationAstellas pharma incAstellas enterLicense agreementNovel bispecific macrophageAstellas pharmaBispecific macrophage engager platformTumor associated macrophageTumor microenvironmentChief strategy officerPrimary focuses

Astellas Completes Acquisition of Propella Therapeutics

Astellas Completes Acquisition of Propella Therapeutics
webwire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from webwire.com Daily Mail and Mail on Sunday newspapers.

Naoki okamuraWilliam mooreAstellas pharma incPropella therapeutics incAstellas completes acquisitionPropella therapeuticsTime decemberFocus area approachPress release imageRl 02Next generationPress releaseEws release

Astellas' VEOZATM (fezolinetant) Approved by European Commission for Treatment of Vasomotor Symptoms Associated with Menopause

Astellas' VEOZATM (fezolinetant) Approved by European Commission for Treatment of Vasomotor Symptoms Associated with Menopause
webwire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from webwire.com Daily Mail and Mail on Sunday newspapers.

United statesNaoki okamuraRossella nappiPrzegl menopauzalnyJ public healthHealth qual life outcomesEuropean commissionHead of biopharma developmentSan matteo foundationResearch centerAstellas pharma incEuropean medicines agencyUniversity of paviaEuropean union eu member statesEuropean unionEuropean commission for treatment of vasomotor symptoms

European Medicines Agency Accepts Astellas' Marketing Authorization Application for Zolbetuximab

European Medicines Agency Accepts Astellas' Marketing Authorization Application for Zolbetuximab
webwire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from webwire.com Daily Mail and Mail on Sunday newspapers.

Moitreyee chatterjee kishoreNaoki okamuraOncology developmentAstellas pharma incEuropean commissionCommittee for medicinal products human useEuropean medicines agencySenior vice presidentImmuno oncology developmentMedicinal productsHuman usePress release imageFirst in classLdn182 targetedFirst lineHer2 negative

Phase 3b Trial of Fezolinetant Shows Positive Topline Results for Treatment of VMS Due to Menopause

Phase 3b Trial of Fezolinetant Shows Positive Topline Results for Treatment of VMS Due to Menopause
webwire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from webwire.com Daily Mail and Mail on Sunday newspapers.

Naoki okamuraDrug administrationHead of biopharma developmentAstellas pharma incFezolinetant shows positive topline resultsVice presidentBiopharma developmentPress release imagePress releaseEws release